Suppr超能文献

基于风险分层对英国慢性肾脏病患者从初级保健转诊至专科护理的影响。

Impact of Using Risk-Based Stratification on Referral of Patients With Chronic Kidney Disease From Primary Care to Specialist Care in the United Kingdom.

作者信息

Bhachu Harjeet K, Cockwell Paul, Subramanian Anuradhaa, Adderley Nicola J, Gokhale Krishna, Fenton Anthony, Kyte Derek, Nirantharakumar Krishnarajah, Calvert Melanie

机构信息

Department of Renal Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK.

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

Kidney Int Rep. 2021 Jun 1;6(8):2189-2199. doi: 10.1016/j.ekir.2021.05.031. eCollection 2021 Aug.

Abstract

INTRODUCTION

The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of end-stage renal disease (ESRD) has been developed, but its potential impact in a population on referrals for patients with chronic kidney disease (CKD) from primary to specialty nephrology care is not known.

METHODS

A cross-sectional population-based study of individuals in United Kingdom primary care registered in The Health Improvement Network database was conducted. National Institute of Health and Care Excellence (NICE) 2014 CKD guidelines the 4-variable KFRE set at a >3% risk of ESRD at 5 years were applied to patients identified with CKD stage 3-5 between January 1, 2016, and March 31, 2017.

RESULTS

In all, 39,476 (36.6%) of 107,962 adults with CKD stage 3-5 had a urine albumin:creatinine ratio (ACR) available and entered into the primary analysis. Of that, 7566 (19.2%) patients fulfilled NICE criteria for referral, 2386 (31.5%) of whom had a ≤3% 5-year risk of ESRD. Also 8663 (21.9%) patients had a >3% 5-year risk of ESRD, 3483 (40.2%) of whom did not fulfill NICE criteria; this represents 8.8% of the primary population. By using the KFRE threshold rather than NICE criteria for referral, 5869 patients (14.9% of the primary analysis population) would have been reallocated between primary and specialist care. Imputational analysis was used for missing ACR measurements and showed similar results.

CONCLUSIONS

A risk-based referral approach would lead to a substantial reallocation of patients between primary care and specialist nephrology care with only a small increase in numbers eligible, ensuring those at higher risk of progression are identified.

摘要

引言

用于预测终末期肾病(ESRD)风险的经过外部验证的肾衰竭风险方程(KFRE)已被开发出来,但其对慢性肾病(CKD)患者从初级肾病护理转诊至专科肾病护理人群的潜在影响尚不清楚。

方法

对英国初级保健机构中登记在健康改善网络数据库中的个体进行了一项基于人群的横断面研究。将英国国家卫生与临床优化研究所(NICE)2014年CKD指南中设定的5年ESRD风险>3%的四变量KFRE应用于2016年1月1日至2017年3月31日期间确诊为3-5期CKD的患者。

结果

在107,962名3-5期CKD成人中,共有39,476名(36.6%)患者有尿白蛋白:肌酐比值(ACR)数据并纳入初步分析。其中,7566名(19.2%)患者符合NICE转诊标准,其中2386名(31.5%)患者5年ESRD风险≤3%。此外,8663名(21.9%)患者5年ESRD风险>3%,其中3483名(40.2%)患者不符合NICE标准;这占主要人群的8.8%。通过使用KFRE阈值而非NICE转诊标准,5869名患者(占初步分析人群的14.9%)将在初级护理和专科护理之间重新分配。对缺失的ACR测量值采用插补分析,结果相似。

结论

基于风险的转诊方法将导致患者在初级护理和专科肾病护理之间大量重新分配,符合条件的人数仅略有增加,确保识别出进展风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48da/8343777/5939c9628aa5/fx1.jpg

相似文献

4
5
Use of kidney failure risk equation as a tool to evaluate referrals from primary care to specialist nephrology care.
Intern Med J. 2024 Jul;54(7):1126-1135. doi: 10.1111/imj.16377. Epub 2024 Mar 26.
7
External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):609-15. doi: 10.2215/CJN.08110715. Epub 2016 Jan 19.
9
Validation of the Kidney Failure Risk Equation in Manitoba.
Can J Kidney Health Dis. 2017 Apr 20;4:2054358117705372. doi: 10.1177/2054358117705372. eCollection 2017.
10
The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study.
Kidney Med. 2021 Oct 15;4(1):100375. doi: 10.1016/j.xkme.2021.08.010. eCollection 2022 Jan.

引用本文的文献

2
Risk Stratification for CKD Progression in Primary Care.
Kidney Int Rep. 2025 Mar 6;10(5):1559-1561. doi: 10.1016/j.ekir.2025.02.037. eCollection 2025 May.
3
Recalibrating the kidney failure risk equation for a Mediterranean European population: reducing age and sex inequality.
Front Med (Lausanne). 2025 Jan 29;11:1497780. doi: 10.3389/fmed.2024.1497780. eCollection 2024.
4
When impact trials are not feasible: alternatives to study the impact of prediction models on clinical practice.
Nephrol Dial Transplant. 2024 Dec 20;40(1):27-33. doi: 10.1093/ndt/gfae170.
6
Clinical Decision Support Tools in the Electronic Medical Record.
Kidney Int Rep. 2023 Oct 29;9(1):29-38. doi: 10.1016/j.ekir.2023.10.019. eCollection 2024 Jan.
7
Implementation of the Kidney Failure Risk Equation in a United States Nephrology Clinic.
Kidney Int Rep. 2023 Sep 12;8(12):2665-2676. doi: 10.1016/j.ekir.2023.09.001. eCollection 2023 Dec.
9
Implementing a Formalized Risk-Based Approach to Determine Candidacy for Multidisciplinary CKD Care: A Descriptive Cohort Study.
Can J Kidney Health Dis. 2023 Dec 1;10:20543581231215865. doi: 10.1177/20543581231215865. eCollection 2023.
10
Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD.
Am J Kidney Dis. 2023 Oct;82(4):386-394.e1. doi: 10.1053/j.ajkd.2023.03.014. Epub 2023 Jun 8.

本文引用的文献

2
Prediction of kidney failure in children with chronic kidney disease and obstructive uropathy.
Pediatr Nephrol. 2021 Jan;36(1):111-118. doi: 10.1007/s00467-020-04661-w. Epub 2020 Jun 25.
3
Validation of the Kidney Failure Risk Equation in Kidney Transplant Recipients.
Can J Kidney Health Dis. 2020 May 25;7:2054358120922627. doi: 10.1177/2054358120922627. eCollection 2020.
4
Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound Parameters.
Can J Kidney Health Dis. 2020 Mar 18;7:2054358120911274. doi: 10.1177/2054358120911274. eCollection 2020.
6
Accuracy of Kidney Failure Risk Equation in Transplant Recipients.
Kidney Int Rep. 2019 May 22;4(9):1334-1337. doi: 10.1016/j.ekir.2019.05.009. eCollection 2019 Sep.
7
Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial.
Can J Kidney Health Dis. 2019 May 29;6:2054358119841611. doi: 10.1177/2054358119841611. eCollection 2019.
9
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.
10
Towards the best kidney failure prediction tool: a systematic review and selection aid.
Nephrol Dial Transplant. 2020 Sep 1;35(9):1527-1538. doi: 10.1093/ndt/gfz018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验